Human Anti-LILRA4 scFv-Fc Chimera (VS-0325-FY103)

CAT#: VS-0325-FY103

The anti-LILRA4 scFv-Fc antibody is designed to specifically target LILRA4, a receptor involved in immune regulation. It is engineered with a scFv-Fc format to enhance stability and prolong half-life in vivo. This antibody can be used in both in vitro and in vivo studies to explore the role of LILRA4 in diseases like cancer and autoimmune disorders.

Gene Expression
Figure 1 IHC staining of human lymph node Figure 2 Colon Figure 3 Kidney Figure 4 Testis

Specifications

  • Host Species
  • Human
  • Type
  • Human IgG1, scFv-Fc
  • Specificity
  • Human LILRA4
  • Species Reactivity
  • Human
  • Applications
  • Flow Cytometry
  • Related Disease
  • Cancer, autoimmune disease

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
  • Shipping
  • Ice packs

Target

  • Alternative Names
  • ILT7; CD85g
  • Long Name
  • leukocyte immunoglobulin like receptor A4
  • Cellular Localization
  • Cell membrane
  • Post Translation Modifications
  • Glycosylation at Asn138, Asn239, Asn279, and Asn300
    Modification sites at PhosphoSitePlus
    Glycosylation from GlyGen 4 sites
  • Function
  • Functions coreceptor to limit the innate immune responses to viral infections; signaling occurs via FCER1G (PubMed:16735691, 19564354).
    Down-regulates the production of IFNA1, IFNA2, IFNA4, IFNB1 and TNF by plasmacytoid dendritic cells that have been exposed to influenza virus or cytidine-phosphate-guanosine (CpG) dinucleotides, indicating it functions as a negative regulator of TLR7 and TLR9 signaling cascades.
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for VS-0325-FY103. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Isotype Control

Secondary Antibody

See other products for "LILRA4"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
HPAB-N0168-YC-S(P) Human Anti-LILRA4 Recombinant Antibody; scFv Fragment (HPAB-N0168-YC-S(P)) FC, ELISA, FuncS Humanized scFv
CAT Product Name Application Type
HPAB-N0168-YC-F(E) Human Anti-LILRA4 Recombinant Antibody; Fab Fragment (HPAB-N0168-YC-F(E)) FC, ELISA, FuncS Humanized Fab
CAT Product Name Application Type
VS-0425-YC459 Recombinant Anti-LILRA4 Vesicular Antibody, EV Displayed (VS-0425-YC459) ELISA, FC, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare